Read More Pharma Industry News What the LEGION-100 trial could mean for the future of combination immunotherapy strategies Can the LEGION-100 trial redefine immunotherapy strategies? Explore what Syncromune Inc.’s approach means for oncology and future cancer treatments. bySoujanya RaviMay 1, 2026